Loading news...
GSK PLC (LSE:GSK, NYSE:GSK) said on Wednesday that a potential new treatment for chronic hepatitis B had delivered positive late-stage trial results,...
GSK PLC (LSE:GSK, NYSE:GSK) said Japan has approved Exdensur (depemokimab) to treat severe or refractory bronchial asthma and chronic rhinosinusitis with...
FTSE 100 down 38 points at 9,860 UK GDP grew 0.1% in Q3, Q2 revised down to 0.2% CBI survey adds to gloomy picture of economy GSK agrees MFN pricing deal...
8.16am: FTSE losing some weight The FTSE has lost some pre-Christmas weight in initial Monday dealings, with defensives on the slide, including utilities,...
HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has provided an update on its Rudyard Project in Montana as it moves closer to first helium production. The...
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) said it remains confident that its mining lease for the Ewoyaa lithium project will be ratified,...
GSK PLC (LSE:GSK, NYSE:GSK) has become the latest big pharma company to fall into line with the US government's "most favoured nation" drug pricing regime,...
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) has announced the successful commissioning and first gas production at its Galactica helium plant in Colorado....
GSK PLC (LSE:GSK, NYSE:GSK) has picked up another regulatory boost for its experimental cancer medicine risvutatug rezetecan, after the US Food and Drug...
7.54am: GSK steps up US dispute GSK PLC (LSE:GSK, NYSE:GSK) has stepped up a dispute over rights to its fast-growing cancer drug Jemperli in the US courts....
GSK PLC (LSE:GSK, NYSE:GSK) has stepped up a dispute over rights to its fast-growing cancer drug Jemperli by having its US subsidiary Tesaro sue AnaptysBio...